Emergence in Spain of a multidrug-resistant Enterobacter cloacae clinical isolate producing SFO-1 extended-spectrum β-lactamase

Journal of Clinical Microbiology

Volumn 49, Issue 3, 2011, Pages 822-828

  Fernández, Ana ^a   Pereira, María José ^a   Suárez, José Manuel ^a   Poza, Margarita ^a   Treviño, Mercedes ^b   Villalón, Pilar ^c   Sáez Nieto, Juan Antonio ^c   Regueiro, Benito José ^b   Villanueva, Rosa ^a   Bou, Germán ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; PIPERACILLIN; PROTEIN SFO 1; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

AAC3 GENE; ADULT; AGED; AMPA GENE; AMPR GENE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; EPIDEMIC; FEMALE; GENE DOSAGE; GENE LOCATION; GENE SEQUENCE; HOSPITALIZATION; HUMAN; INVERTED REPEAT; MALE; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK ASSESSMENT; RISK FACTOR; SPAIN; TRACHEOSTOMY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CLONING, MOLECULAR; DISEASE OUTBREAKS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SPAIN;

ENTEROBACTER CLOACAE;

EID: 79952342785     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01872-10     Document Type: Article

References (44)

1. Bradford, P. A. 2001. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
2. Canton, R., T. M. Coque, and F. Baquero. 2003. Multi-resistant Gramnegative bacilli: from epidemics to endemics. Curr. Opin. Infect. Dis. 16:315-325.
3. Carrer, A., et al. 2009. Outbreak of CTX-M-15-producing Klebsiella pneumoniae in the intensive care unit of a French hospital. Microb. Drug Resist. 15:47-54.
4. Conte, M. P., et al. 2005. Extended spectrum beta-lactamase-producing Klebsiella pneumoniae outbreaks during a third generation cephalosporin restriction policy. J. Chemother. 17:66-73. (Pubitemid 40463759)
5. Fang, H., et al. 2004. Molecular epidemiological analysis of Escherichia coli isolates producing extended-spectrum beta-lactamases for identification of nosocomial outbreaks in Stockholm, Sweden. J. Clin. Microbiol. 42:5917-5920.
6. Fernandez, A., et al. 2007. Interspecies spread of CTX-M-32 extendedspectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression. J. Antimicrob. Chemother. 59:841-847.
7. Ford, P. J., and M. B. Avison. 2004. Evolutionary mapping of the SHV beta-lactamase and evidence for two separate IS26-dependent blaSHV mobilization events from the Klebsiella pneumoniae chromosome. J. Antimicrob. Chemother. 54:69-75.
8. Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16:128-140.
9. Golebiewski, M., et al. 2007. Complete nucleotide sequence of the pCTX-M3 plasmid and its involvement in spread of the extended-spectrum beta-lactamase gene blaCTX-M-3. Antimicrob. Agents Chemother. 51:3789-3795.
10. Gouby, A., et al. 1994. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J. Clin. Microbiol. 32:301-305.
11. Grisold, A. J., et al.. Use of automated repetitive-sequence-based PCR for rapid laboratory confirmation of nosocomial outbreaks. J. Infect. 60:44-51.
12. Hyle, E. P., et al. 2005. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Clin. Infect. Dis. 40:1317-1324.
13. Jacoby, G. A. 2009. AmpC beta-lactamases. Clin. Microbiol. Rev. 22:161-182.
14. Jiang, X., et al. 2005. Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China. J. Clin. Microbiol. 43:826-831.
15. Kartali, G., et al. 2002. Outbreak of infections caused by Enterobacter cloacae producing the integron-associated beta-lactamase IBC-1 in a neonatal intensive care unit of a Greek hospital. Antimicrob. Agents Chemother. 46:1577-1580.
16. Kelesidis, T., D. E. Karageorgopoulos, I. Kelesidis, and M. E. Falagas. 2008. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J. Antimicrob. Chemother. 62:895-904.
17. Kim, Y. K., et al. 2002. Bloodstream infections by extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob. Agents Chemother. 46:1481-1491.
18. Lee, C. C., et al. 2010. Bacteremia due to extended-spectrum-beta- lactamase-producing Enterobacter cloacae: role of carbapenem therapy. Antimicrob. Agents Chemother. 54:3551-3556.
19. Lin, M. F., M. L. Huang, and S. H. Lai. 2003. Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. J. Hosp. Infect. 53:39-45.
20. Manzur, A., et al. 2007. Nosocomial outbreak due to extended- spectrumbeta-lactamase-producing Enterobacter cloacae in a cardiothoracic intensive care unit. J. Clin. Microbiol. 45:2365-2369.
21. Mathew, A., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J. Gen. Microbiol. 88:169-178.
22. Matsumoto, Y., and M. Inoue. 1999. Characterization of SFO-1, a plasmid-mediated inducible class A beta-lactamase from Enterobacter cloacae. Antimicrob. Agents Chemother. 43:307-313.
23. McGregor, J. C., et al. 2005. Utility of the chronic disease score and Charlson comorbidity index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am. J. Epidemiol. 161:483-493.
24. Mena, A., et al. 2006. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J. Clin. Microbiol. 44:2831-2837.
25. Miriagou, V., A. Carattoli, E. Tzelepi, L. Villa, and L. S. Tzouvelekis. 2005. IS26-associated In4-type integrons forming multiresistance loci in enterobacterial plasmids. Antimicrob. Agents Chemother. 49:3541-3543.
26. Moissenet, D., et al. 2010. Meningitis caused by Escherichia coli producing TEM-52 extended-spectrum beta-lactamase within an extensive outbreak in a neonatal ward: epidemiological investigation and characterization of the strain. J. Clin. Microbiol. 48:2459-2463.
27. Moriguchi, N., et al. 2007. Outbreak of CTX-M-3-type extended-spectrum beta-lactamase-producing Enterobacter cloacae in a pediatric ward. J. Infect. Chemother. 13:263-266.
28. Ortega, M., et al. 2009. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J. Antimicrob. Chemother. 63:568-574.
29. Paauw, A., A. C. Fluit, J. Verhoef, and M. A. Leverstein-van Hall. 2006. Enterobacter cloacae outbreak and emergence of quinolone resistance gene in Dutch hospital. Emerg. Infect. Dis. 12:807-812.
30. Paauw, A., et al. 2007. Failure to control an outbreak of qnrA1-positive multidrug-resistant Enterobacter cloacae infection despite adequate implementation of recommended infection control measures. J. Clin. Microbiol. 45:1420-1425.
31. Paterson, D. L. 2006. Resistance in Gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control 34:S20-S28, S64-S73.
32. Paterson, D. L., et al. 2001. Control of an outbreak of infection due to extended-spectrum beta-lactamase-producing Escherichia coli in a liver transplantation unit. Clin. Infect. Dis. 33:126-128.
33. Pitout, J. D., et al. 2009. Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15. J. Clin. Microbiol. 47:1212-1215.
34. Reddy, P., et al. 2007. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin. Infect. Dis. 45:846-852.
35. Rodriguez-Bano, J., and A. Pascual. 2008. Clinical significance of extended-spectrum beta-lactamases. Expert Rev. Anti Infect. Ther. 6:671-683.
36. Sanders, W. E., Jr., and C. C. Sanders. 1997. Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin. Microbiol. Rev. 10:220-241.
37. Tenover, F. C. 2007. Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond. Clin. Infect. Dis. 44:418-423.
38. Tenover, F. C., et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
39. Trevino, M., L. Moldes, L. Martinez-Lamas, C. Varon, and B. J. Regueiro. 2009. Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-beta-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain). Eur. J. Clin. Microbiol. Infect. Dis. 28:1253-1258.
40. Tumbarello, M., et al. 2004. ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. J. Antimicrob. Chemother. 53:277-282.
41. Tumbarello, M., et al. 2008. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob. Agents Chemother. 52:3244-3252.
42. Tumbarello, M., et al. 2006. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob. Agents Chemother. 50:498-504.
43. Velasco, C., et al. 2009. Eradication of an extensive outbreak in a neonatal unit caused by two sequential Klebsiella pneumoniae clones harbouring related plasmids encoding an extended-spectrum beta-lactamase. J. Hosp. Infect. 73:157-163.
44. Vranic-Ladavac, M., et al. 2010. Clonal spread of CTX-M-15-producing Klebsiella pneumoniae in a Croatian hospital. J. Med. Microbiol. 59:1069-1078.